Compumedics Ltd (CMP)-医療機器分野:企業M&A・提携分析

◆英語タイトル:Compumedics Ltd (CMP) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8011051
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月21日
◆ページ数:31
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:オーストラリア
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Compumedics Ltd (Compumedics) is a medical device company that develops and commercializes computer-based medical products for recording and diagnostics market. The company designs, develops and commercializes computer aided medical diagnostic systems. Its product categories comprise sleep diagnostics, neurology diagnostics, brain research, transcranial doppler and others. Compumedics offers ambulatory products, home sleep testing, cardio respiratory resting, software and accessories, laboratory based products, clinical and ambulatory ECG solutions, CEEG monitoring, and other diagnostic products. The company caters to hospitals, institutions, neuro-diagnostics and brain research, medical clinics, and home service providers. It collaborates with various medical and research communities. The company operates in Australia, France, Germany and the US. Compumedics is headquartered in Abbotsford, Victoria, Australia.

Compumedics Ltd (CMP) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Compumedics Ltd, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Compumedics Ltd, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Compumedics Ltd, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Compumedics Ltd, Medical Equipment, Deals By Market, 2011 to YTD 2017 8
Compumedics Ltd, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Compumedics Ltd, Medical Equipment, Deal Details 10
Partnerships 10
Compumedics Enters into Distribution Agreement with Kwangwon Medical 10
Equity Offering 11
Compumedics Completes Public Offering Of Shares For US$0.24 Million 11
Acquisition 12
Beijing Best-Med Development Acquires Stake In Compumedics For US$0.5 Million 12
Compumedics Ltd – Key Competitors 13
Compumedics Ltd – Key Employees 14
Compumedics Ltd – Locations And Subsidiaries 15
Head Office 15
Other Locations & Subsidiaries 15
Recent Developments 16
Financial Announcements 16
Aug 28, 2017: Compumedics: Business Update: APPENDIX 4E Release 16
Feb 28, 2017: Compumedics Announces Financial Results For Half-Year Ended 31 December 2016 18
Jul 18, 2016: On track for increased sales and profits in FY16 Further growth expected in FY17 20
Feb 25, 2016: BUSINESS UPDATE: Appendix 4D Release 21
Corporate Communications 23
Feb 22, 2017: Compumedics USA Management Strengthened to Deliver Core Business Growth 23
Other Significant Developments 24
Sep 21, 2017: Compumedics Wins Major Neurological Monitoring Contract With Leading European Epilepsy Center 24
Jul 07, 2017: Compumedics business update – July 2017 25
May 17, 2017: Compumedics: $3 Million In New Orders For China 26
Jun 08, 2016: $700K Confirmed Order Strengthens Compumedics’ Growth into China and Strategic Meg Appointment 27
Apr 14, 2016: Growth Trajectory on Track – Record $2 Million Sales Week 29
Jan 27, 2016: Business Update – On Track For Guidance And Continued Growth In 2016 30
Appendix 31
Methodology 31
About GlobalData 31
Contact Us 31
Disclaimer 31

List of Tables
Compumedics Ltd, Medical Equipment, Key Facts, 2017 2
Compumedics Ltd, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
Compumedics Ltd, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Compumedics Ltd, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Compumedics Ltd, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Compumedics Ltd, Deals By Market, 2011 to YTD 2017 8
Compumedics Ltd, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Compumedics Enters into Distribution Agreement with Kwangwon Medical 10
Compumedics Completes Public Offering Of Shares For US$0.24 Million 11
Beijing Best-Med Development Acquires Stake In Compumedics For US$0.5 Million 12
Compumedics Ltd, Key Competitors 13
Compumedics Ltd, Key Employees 14
Compumedics Ltd, Subsidiaries 15

★海外企業調査レポート[Compumedics Ltd (CMP)-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Aquinox Pharmaceuticals Inc (AQXP)-製薬・医療分野:企業M&A・提携分析
    Summary Aquinox Pharmaceuticals Inc (Aquinox) is a clinical-stage pharmaceutical company which develops targeted therapeutics in the areas of inflammation and immuno-oncology. The company's lead product candidate AQX-1125, is a SHIP1 activator which is a natural modulator of the PI3K pathway to redu …
  • Sime Darby Bhd (SIME)
    Sime Darby Bhd (SIME) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company
  • Aptus Health Inc:医療機器:M&Aディール及び事業提携情報
    Summary Aptus Health Inc (Aptus), formerly Physicians Interactive Inc, a subsidiary of Merck & Co Inc, is a technology company that provides healthcare digital marketing solutions. The company offers strategy, solution design, customer segmentation, advertising, actionable analytic, commercial, paym …
  • Taiwan Liposome Company Ltd (4152):製薬・医療:M&Aディール及び事業提携情報
    Summary Taiwan Liposome Company Ltd (TLC) is a clinical-stage pharmaceutical company that develops and commercializes novel nanomedicines based on drug delivery technology platform. The company’s pipeline products include TLC599, TLC590, TLC399 and TLC178. Its TLC 178 is used for the treatment of ad …
  • NovoCure Ltd (NVCR):企業の製品パイプライン分析
    Summary NovoCure Ltd (NovoCure) develops and commercializes novel delivery systems for the treatment of cancers of brain, abdomen, and torso. Its proprietary Tumor Treating Fields (TTF) technology platform uses electric fields tuned to specific frequencies for disrupting the division solid tumor can …
  • Response Biomedical Corp:医療機器:M&Aディール及び事業提携情報
    Summary Response Biomedical Corp (Response Biomedical) focuses on the research, development, manufacture and marketing of diagnostic technologies for the point-of-care (POC), central-lab testing and on-site environmental testing markets. It offers Cardiovascular tests such as Troponin-I, Myoglobin, …
  • FirstEnergy Corp:発電所・企業SWOT分析
    FirstEnergy Corp - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees (e …
  • Wirecard AG:企業の戦略・SWOT・財務分析
    Wirecard AG - Strategy, SWOT and Corporate Finance Report Summary Wirecard AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Seres Therapeutics Inc (MCRB):製薬・医療:M&Aディール及び事業提携情報
    Summary Seres Therapeutics Inc (Seres), is a microbiome therapeutics platform company that develops a novel class of biological drugs. The company creates a new class of medicines to treat diseases resulting from functional deficiencies in the microbiome, a condition known as dysbiosis. The company’ …
  • Weatherford International Plc (WFT):石油・ガス:M&Aディール及び事業提携情報
    Summary Weatherford International Plc (Weatherford) is an oilfield service provider. The company offers equipment and services utilized in the drilling, evaluation, completion, production and intervention of oil and natural gas wells. Its product line includes artificial lift systems, completion sys …
  • Tempur Sealy International, Inc.:企業の戦略・SWOT・財務情報
    Tempur Sealy International, Inc. - Strategy, SWOT and Corporate Finance Report Summary Tempur Sealy International, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • RegeneRx Biopharmaceuticals Inc (RGRX):企業の財務・戦略的SWOT分析
    Summary RegeneRx Biopharmaceuticals Inc (RegeneRx) is a clinical-stage biopharmaceutical company that designs, researches and develops novel peptides targeted at diseases with unmet medical needs. The company offers clinical trials, science and discovery and business development services. Its busine …
  • Samba Financial Group (1090):企業の財務・戦略的SWOT分析
    Samba Financial Group (1090) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • ShawCor Ltd (SCL):企業の財務・戦略的SWOT分析
    ShawCor Ltd (SCL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Neovasc Inc (NVC):企業の財務・戦略的SWOT分析
    Summary Neovasc Inc (Neovasc) is a medical device manufacturing company that manufactures, develops, and sells cardiovascular disease products. The company’s products include Neovasc reducer, Neovasc tiara, and Neovasc tissue products. Its Neovasc tiara is a novel transcatheter device that is design …
  • NovoCure Ltd (NVCR):製薬・医療:M&Aディール及び事業提携情報
    Summary NovoCure Ltd (NovoCure) is an drug company that offers development and commercialization of novel therapies for tumor treating fields. The company’s pipeline products find application in cancer indications such as malignant melanoma, hepatocellular carcinoma, ovarian cancer, breast cancer an …
  • A. Menarini Industrie Farmaceutiche Riunite Srl:企業の戦略的SWOT分析
    A. Menarini Industrie Farmaceutiche Riunite Srl - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competito …
  • Koninklijke Philips NV (PHIA):企業の製品パイプライン分析
    Summary Koninklijke Philips NV (Philips) is a diversified technology company that develops and manufactures medical systems and consumer electronics products. The company offers products and solutions in the areas of diagnostic imaging, enterprise diagnostic informatics, image-guided therapy, ultras …
  • Nobilis Health Corp (NHC):企業の財務・戦略的SWOT分析
    Summary Nobilis Health Corp (Nobilis Health), formerly Northstar Healthcare Inc is a healthcare development and management company that offers outpatient surgery and healthcare solutions. The center’s services include surgical services, surgery and critical patient education services. Its surgical s …
  • Storopack Hans Reichenecker GmbH:企業の戦略的SWOT分析
    Storopack Hans Reichenecker GmbH - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pr …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆